Evidence map›Paper›PMID 11086021›Full record

ReviewThe Journal of clinical investigation2000

Tangier disease as a test of the reverse cholesterol transport hypothesis.

A R Tall, N Wang

Abstract readReviewComment
In one paragraph

Review in The Journal of clinical investigation, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Pathways and Mechanisms of Cellular Cholesterol Efflux-Insight From Imaging.Frontiers in cell and developmental biology · 2022
    Review
  6. PPARInternational journal of hypertension · 2019
    Review
  7. Article
  8. Article
  9. Apolipoprotein A-I: A Molecule of Diverse Function.Indian journal of clinical biochemistry : IJCB · 2016
    Review
  10. Nephrotic syndrome caused by immune-mediated acquired LCAT deficiency.Journal of the American Society of Nephrology : JASN · 2013
    Article
  11. Article
  12. MicroRNA-33 encoded by an intron of sterol regulatory element-binding protein 2 (Srebp2) regulates HDL in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2010
    Article
  13. Article
  14. A possible mechanism linking hyperglycemia and reduced high-density lipoprotein cholesterol levels in diabetes.Journal of Huazhong University of Science and Technology. Medical sciences = Hua zhong ke ji da xue xue bao. Yi xue Ying De wen ban = Huazhong keji daxue xuebao. Yixue Yingdewen ban · 2010
    Article
  15. Article
  16. Article
  17. Article
  18. Genetics of premature myocardial infarction.Current atherosclerosis reports · 2008
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors.

A R TallDivision of Molecular Medicine, Department of Medicine, Columbia University, New York, New York 10032, USA. art1@columbia.edu
N Wang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsArteriosclerosisATP Binding Cassette Transporter 1ATP-Binding Cassette TransportersBiological TransportCholesterolHumansLipoproteins, HDLTangier DiseaseATP Binding Cassette Transporter 1ATP-Binding Cassette TransportersCholesterolLipoproteins, HDL

Identifiers

PMID11086021
PMCPMC381442

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.